Literature DB >> 22655166

Clinically unrecognized mitral regurgitation is prevalent in lone atrial fibrillation.

Sanjiv Sharma1, Joel Lardizabal, Mark Monterroso, Neil Bhambi, Rohan Sharma, Rasham Sandhu, Sarabjeet Singh.   

Abstract

AIM: To investigate the prevalence of clinically unrecognized mitral regurgitation (MR) in lone atrial fibrillation (AF).
METHODS: We studied the prevalence and severity of MR by transesophageal echocardiography (TEE) in patients with "lone" AF as compared to a matched cohort of patients in normal sinus rhythm (NSR) undergoing TEE for other indications besides recognized valvular heart disease.
RESULTS: A total of 157 subjects (57 in the AF group and 100 in the NSR group) with structurally normal cardiac valves were included in the study. In the AF group, moderate MR or more was noted in 66% of the patients, mild MR in 18%, trace or no MR in 16%. In the control group, moderate MR was noted in 6% of patients, mild MR 31%, trace or no MR in 63 % of patients. Moderate MR or greater was significantly more prevalent in the AF group compared to the NSR group (66% vs 6%, P < 0.0001).
CONCLUSION: Clinically unrecognized moderate MR is prevalent in "lone" AF -either as an etiologic factor leading to "lone" AF or developing after onset of AF.

Entities:  

Keywords:  Lone atrial fibrillation; Mitral regurgitation; Normal sinus rhythm

Year:  2012        PMID: 22655166      PMCID: PMC3364504          DOI: 10.4330/wjc.v4.i5.183

Source DB:  PubMed          Journal:  World J Cardiol


  27 in total

1.  Atrial fibrosis and lone atrial fibrillation: an ominous association from the beginning?

Authors:  Claudio Tondo
Journal:  Heart Rhythm       Date:  2010-07-15       Impact factor: 6.343

2.  Mitral regurgitation in lone atrial fibrillation: more than a matter of annular size.

Authors:  Jeffrey J Silbiger
Journal:  Echocardiography       Date:  2010-02       Impact factor: 1.724

3.  Increased amount of atrial fibrosis in patients with atrial fibrillation secondary to mitral valve disease.

Authors:  Guillaume S C Geuzebroek; Shirley C M van Amersfoorth; Mark G Hoogendijk; Johannes C Kelder; Norbert M van Hemel; Jacques M T de Bakker; Ruben Coronel
Journal:  J Thorac Cardiovasc Surg       Date:  2011-10-19       Impact factor: 5.209

4.  Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.

Authors:  Charles R Kerr; Karin H Humphries; Mario Talajic; George J Klein; Stuart J Connolly; Martin Green; John Boone; Robert Sheldon; Paul Dorian; David Newman
Journal:  Am Heart J       Date:  2005-03       Impact factor: 4.749

5.  Impact of atrial fibrillation on tricuspid and mitral annular dilatation and valvular regurgitation.

Authors:  Xiaoyan Zhou; Yutaka Otsuji; Shiro Yoshifuku; Toshinori Yuasa; Hui Zhang; Kunitsugu Takasaki; Keiko Matsukida; Akira Kisanuki; Shinichi Minagoe; Chuwa Tei
Journal:  Circ J       Date:  2002-10       Impact factor: 2.993

6.  Mitral valve repair for severe mitral regurgitation secondary to lone atrial fibrillation.

Authors:  Hunaid A Vohra; Robert N Whistance; Ahmed Magan; Sayed A Sadeque; Steve A Livesey
Journal:  Eur J Cardiothorac Surg       Date:  2012-02-08       Impact factor: 4.191

7.  Left atrial enlargement as a predictor of recurrences in lone paroxysmal atrial fibrillation.

Authors:  Valerio Zacà; Maurizio Galderisi; Sergio Mondillo; Marta Focardi; Piercarlo Ballo; Francesco Guerrini
Journal:  Can J Cardiol       Date:  2007-09       Impact factor: 5.223

8.  The natural history of lone atrial fibrillation. A population-based study over three decades.

Authors:  S L Kopecky; B J Gersh; M D McGoon; J P Whisnant; D R Holmes; D M Ilstrup; R L Frye
Journal:  N Engl J Med       Date:  1987-09-10       Impact factor: 91.245

9.  Does treatment with ACE inhibitors prevent the long term recurrences of lone atrial fibrillation after cardioversion?

Authors:  Mihaela Grecu; Ramona Oana Olteanu; St S Olteanu; Cătălina Arsenescu Georgescu
Journal:  Rom J Intern Med       Date:  2007

10.  Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.

Authors:  Fabio Belluzzi; Laura Sernesi; Paola Preti; Francesco Salinaro; Maria Luisa Fonte; Stefano Perlini
Journal:  J Am Coll Cardiol       Date:  2009-01-06       Impact factor: 24.094

View more
  2 in total

1.  Quantitative analysis of mitral valve morphology in atrial functional mitral regurgitation using real-time 3-dimensional echocardiography atrial functional mitral regurgitation.

Authors:  Tao Cong; Jinping Gu; Alex Pui-Wai Lee; Zhijuan Shang; Yinghui Sun; Qiaobing Sun; Hong Wei; Na Chen; Siyao Sun; Tingting Fu
Journal:  Cardiovasc Ultrasound       Date:  2018-08-21       Impact factor: 2.062

2.  Characterization of Atrial and Ventricular Structural Remodeling in a Porcine Model of Atrial Fibrillation Induced by Atrial Tachypacing.

Authors:  Carlotta Citerni; Jeppe Kirchhoff; Lisbeth Høier Olsen; Stefan Michael Sattler; Fabio Gentilini; Monica Forni; Augusta Zannoni; Morten Grunnet; Nils Edvardsson; Bo Hjorth Bentzen; Jonas Goldin Diness
Journal:  Front Vet Sci       Date:  2020-04-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.